Abstract
Purpose of the review
Ferulic acid (FA), which occurs naturally as the feruloylated sugar ester in grains, fruits, and vegetables, is critical for combating oxidative stress and alleviating neurodegenerative diseases resulting from free radical-generated protein aggregates in brain cells. However, FA cannot be absorbed in conjugated form. Therefore, strategies to improve the bioavailability of FA are gaining more importance. Ferulic acid esterases (FAE) of the gut microbiota are critical enzymes that facilitate FA release from feruloylated sugar ester conjugates and influence systemic health. This review provides insight into a nutrition-based approach to preventing neurodegenerative disorders such as Alzheimer’s and Parkinson’s by altering the diversity of FAE-producing gut microbiota.
Recent findings
The human gut is a niche for a highly dense microbial population. Nutrient components and the quality of food shape the gut microbiota. Microbiota–diet–host interaction primarily involves an array of enzymes that hydrolyse complex polysaccharides and release covalently attached moieties, thereby increasing their bio-accessibility. Moreover, genes encoding polysaccharide degrading enzymes are substrate inducible, giving selective microorganisms a competitive advantage in scavenging nutrients.
Summary
Nutraceutical therapy using specific food components holds promise as a prophylactic agent and as an adjunctive treatment strategy in neurotherapeutics, as it results in upregulation of polysaccharide utilisation loci containing fae genes in the gut microbiota, thereby increasing the release of FA and other antioxidant molecules and combat neurodegenerative processes.
Similar content being viewed by others
Data availability
All data relevent to this study are included in the review.
References
Saxena S, Caroni P (2011) Selective neuronal vulnerability in neurodegenerative diseases from stressor thresholds to degeneration. Neuron 71:35–48. https://doi.org/10.1016/j.neuron.2011.06.031
Virmani A, Pinto L, Binienda Z, Ali S (2013) Food, nutrigenomics, and neurodegeneration—neuroprotection by what you eat! Mol Neurobiol 48:353–362. https://doi.org/10.1007/s12035-013-8498-3
Serra D, Almeida LM, Dinis TCP (2020) Polyphenols in the management of brain disorders: modulation of the microbiota-gut-brain axis. Adv Food Nutr Res 91:1–27. https://doi.org/10.1016/bs.afnr.2019.08.001
Fang P, Kazmi SA, Jameson KG, Hsiao EY (2020) The microbiome as a modifier of neurodegenerative disease risk. Cell Host Microbe 28:201–222. https://doi.org/10.1016/j.chom.2020.06.008
Dinan TG, Cryan JF (2017) The microbiome-gut-brain axis in health and disease. Gastroenterol Clin 46:77–89. https://doi.org/10.1016/j.gtc.2016.09.007
Rao M, Gershon MD (2016) The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol 13:517–528. https://doi.org/10.1038/nrgastro.2016.107
Salonen A, Lahti L, Salojärvi J, Holtrop G, Korpela K, Duncan SH et al (2014) Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 8:2218–2230. https://doi.org/10.1038/ismej.2014.63
Choquenet B, Couteau C, Paparis E, Coiffard LJM (2008) Interest of ferulic acid ethyl ester in photoprotective creams: measure of efficacy by in vitro method. Nat Prod Res 22:1467–1471. https://doi.org/10.1080/14786410802144974
Singh YP, Rai H, Singh G, Singh GK, Mishra S, Kumar S et al (2021) A review on ferulic acid and analogues-based scaffolds for the management of Alzheimer’s disease. Eur J Med Chem 215:113278. https://doi.org/10.1016/j.ejmech.2021.113278
Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 40:92–100. https://doi.org/10.3164/jcbn.40.92
Sgarbossa A, Giacomazza D, Di Carlo M (2015) Ferulic acid: a hope for Alzheimer’s disease therapy from plants. Nutrients 7:5764–5782. https://doi.org/10.3390/nu7075246
Chaudhary A, Jaswal VS, Choudhary S, Sonika SA, Beniwal V et al (2019) Ferulic acid: a promising therapeutic phytochemical and recent patents advances. Recent Pat Inflamm Allergy Drug Discov 13:115–123. https://doi.org/10.2174/1872213X13666190621125048
Zhao Z, Moghadasian MH (2008) Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem 109:691–702. https://doi.org/10.1016/j.foodchem.2008.02.039
Mathew S, Abraham TE (2004) Ferulic acid: an antioxidant found naturally in plant cell walls and feruloyl esterases involved in its release and their applications. Crit Rev Biotechnol 24:59–83. https://doi.org/10.1080/07388550490491467
Gopalan N, Nampoothiri KM, Szakacs G, Parameswaran B, Pandey A (2016) Solid-state fermentation for the production of biomass valorizing feruloyl esterase. Biocatal Agric Biotechnol 7:7–13. https://doi.org/10.1016/j.bcab.2016.04.009
Bunzel M, Ralph J, Funk C, Steinhart H (2003) Isolation and identification of a ferulic acid dehydrotrimer from saponified maize bran insoluble fiber. Eur Food Res Technol 217:128–133. https://doi.org/10.1007/s00217-003-0709-0
Uraji M, Kimura M, Inoue Y, Kawakami K, Kumagai Y, Harazono K et al (2013) Enzymatic production of ferulic acid from defatted rice bran by using a combination of bacterial enzymes. Appl Biochem Biotechnol 171:1085–1093. https://doi.org/10.1007/s12010-013-0190-6
Bento-Silva A, Vaz Patto MC, do RosárioBronze M (2018) Relevance, structure and analysis of ferulic acid in maize cell walls. Food Chem 246:360–378. https://doi.org/10.1016/j.foodchem.2017.11.012
Adom KK, Liu RH (2002) Antioxidant activity of grains. J Agric Food Chem 50:6182–6187. https://doi.org/10.1021/jf0205099
Mateo Anson N, van den Berg R, Havenaar R, Bast A, Haenen GRMM (2009) Bioavailability of ferulic acid is determined by its bioaccessibility. J Cereal Sci 49:296–300. https://doi.org/10.1016/j.jcs.2008.12.001
Cani PD (2018) Human gut microbiome: hopes, threats and promises. Gut 67:1716–1725. https://doi.org/10.1136/gutjnl-2018-316723
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR et al (2011) Enterotypes of the human gut microbiome. Nature 473:174–180. https://doi.org/10.1038/nature09944
Groussin M, Mazel F, Alm EJ (2020) Co-evolution and co-speciation of host-gut bacteria systems. Cell Host Microbe 28:12–22. https://doi.org/10.1016/j.chom.2020.06.013
Liang S, Wu X, Jin F (2018) Gut-brain psychology: Rethinking psychology from the microbiota–gut–brain axis. Front Integr Neurosci 12:33. https://doi.org/10.3389/fnint.2018.00033
Klement RJ, Pazienza V (2019) Impact of different types of diet on gut microbiota profiles and cancer prevention and treatment. Medicina 55:84. https://doi.org/10.3390/medicina55040084
Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA et al (2021) Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat Med 27:321–332. https://doi.org/10.1038/s41591-020-01183-8
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE et al (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:623–628. https://doi.org/10.1038/nature25979
Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J et al (2017) The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev 81:e00036-e117. https://doi.org/10.1128/MMBR.00036-17
Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P et al (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:690–703. https://doi.org/10.1016/j.chom.2015.04.004
Murphy K, Curley D, O’Callaghan TF, O’Shea C-A, Dempsey EM, O’Toole PW et al (2017) The composition of human milk and infant faecal microbiota over the first three months of life: a pilot study. Sci Rep 7:40597. https://doi.org/10.1038/srep40597
Lyons KE, Ryan CA, Dempsey EM, Ross RP, Stanton C (2020) Breast milk, a source of beneficial microbes and associated benefits for infant health. Nutrients 12:1039. https://doi.org/10.3390/nu12041039
Heintz-Buschart A, Wilmes P (2018) Human gut microbiome: function matters. Trends Microbiol 26:563–574. https://doi.org/10.1016/j.tim.2017.11.002
Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492–506. https://doi.org/10.1038/s41422-020-0332-7
Derrien M, Alvarez A-S, de Vos WM (2019) The gut microbiota in the first decade of life. Trends Microbiol 27:997–1010. https://doi.org/10.1016/j.tim.2019.08.001
De Filippo C, Di Paola M, Giani T, Tirelli F, Cimaz R (2019) Gut microbiota in children and altered profiles in juvenile idiopathic arthritis. J Autoimmun 98:1–12. https://doi.org/10.1016/j.jaut.2019.01.001
La-ongkham O, Nakphaichit M, Nakayama J, Keawsompong S, Nitisinprasert S (2020) Age-related changes in the gut microbiota and the core gut microbiome of healthy Thai humans. 3 Biotech 10:276. https://doi.org/10.1007/s13205-020-02265-7
Khan M, Mathew BJ, Gupta P, Garg G, Khadanga S, Vyas AK et al (2021) Gut dysbiosis and IL-21 responsein patients with severe COVID-19. Microorganisms 9:1292. https://doi.org/10.3390/microorganisms9061292
Khan M, Sori N (2022) Diet-gut microbiota-brain axis and IgE-mediated food allergy. In: Sayyed RZ, Khan M (eds) Microbiome-gut-brain axis: implications on health. Springer, Singapore, pp 153–168. https://doi.org/10.1007/978-981-16-1626-6_6
Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12:49. https://doi.org/10.3389/fnins.2018.00049
Kuwahara A, Matsuda K, Kuwahara Y, Asano S, Inui T, Marunaka Y (2020) Microbiota-gut-brain axis: enteroendocrine cells and the enteric nervous system form an interface between the microbiota and the central nervous system. Biomed Res 41:199–216. https://doi.org/10.2220/biomedres.41.199
Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M et al (2019) The microbiota-gut-brain axis. Physiol Revn 99:1877–2013. https://doi.org/10.1152/physrev.00018.2018
Colucci-D’Amato L, Speranza L, Volpicelli F (2020) Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sc 21:7777. https://doi.org/10.3390/ijms21207777
Sun Q, Cheng L, Zeng X, Zhang X, Wu Z, Weng P (2020) The modulatory effect of plant polysaccharides on gut flora and the implication for neurodegenerative diseases from the perspective of the microbiota-gut-brain axis. Int J Biol Macromol 164:1484–1492. https://doi.org/10.1016/j.ijbiomac.2020.07.208
Sundman MH, Chen N, Subbian V, Chou Y (2017) The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease. Brain Behav Immun 66:31–44. https://doi.org/10.1016/j.bbi.2017.05.009
Wan X, Zhang K, Ramkumar S, Deny J, Emayavaramban G, Ramkumar MS et al (2019) A review on electroencephalogram-based brain computer interface for elderly disabled. IEEE 7:36380–36387. https://doi.org/10.1109/ACCESS.2019.2903235
Houlden A, Goldrick M, Brough D, Vizi ES, Lénárt N, Martinecz B et al (2016) Brain injury induces specific changes in the cecal microbiota of mice via altered autonomic activity and mucoprotein production. Brain Behave Immun 57:10–20. https://doi.org/10.1016/j.bbi.2016.04.003
Leo EEM, Campos MRS (2020) Effect of ultra-processed diet on gut microbiota and thus its role in neurodegenerative diseases. Nutrition 71:110609. https://doi.org/10.1016/j.nut.2019.110609
Makki K, Deehan EC, Walter J, Bäckhed F (2018) The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23:705–715. https://doi.org/10.1016/j.chom.2018.05.012
Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM et al (2018) An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans. Cell Metab 27:559–571. https://doi.org/10.1016/j.cmet.2018.01.005
Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K et al (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15:73. https://doi.org/10.1186/s12967-017-1175-y
Sakkas H, Bozidis P, Touzios C, Kolios D, Athanasiou G, Athanasopoulou E et al (2020) Nutritional status and the influence of the vegan diet on the gut microbiota and human health. Medicina 56:88. https://doi.org/10.3390/medicina56020088
Liu S, Gao J, Zhu M, Liu K, Zhang H-L (2020) Gut microbiota and dysbiosis in Alzheimer’s disease: implications for pathogenesis and treatment. Mol Neurobiol 57:5026–5043. https://doi.org/10.1007/s12035-020-02073-3
Mills S, Stanton C, Lane JA, Smith GJ, Ross RP (2019) Precision nutrition and the microbiome, part I: current state of the science. Nutrients 11:923. https://doi.org/10.3390/nu11040923
Khan M, Nakkeeran E, Umesh-Kumar S (2013) Potential application of pectinase in developing functional foods. Annu Rev Food Sci Technol 4:21–34. https://doi.org/10.1146/annurev-food-030212-182525
Tomova A, Bukovsky I, Rembert E, Yonas W, Alwarith J, Barnard ND et al (2019) The effects of vegetarian and vegan diets on gut microbiota. Front Nutri 6:47. https://doi.org/10.3389/fnut.2019.00047
Renaud J, Martinoli M-G (2019) Considerations for the use of polyphenols as therapies in neurodegenerative diseases. Int J Mol Sci 20:1883. https://doi.org/10.3390/ijms20081883
Ravi SK, Narasingappa RB, Vincent B (2019) Neuro-nutrients as anti-alzheimer’s disease agents: a critical review. Crit Rev Food Sci Nutr 59:2999–3018. https://doi.org/10.1080/10408398.2018.1481012
Di Meo F, Valentino A, Petillo O, Peluso G, Filosa S, Crispi S (2020) Bioactive polyphenols and neuromodulation: molecular mechanisms in neurodegeneration. Int J Mol Sci 21:2564. https://doi.org/10.3390/ijms21072564
Ma G, Chen Y (2020) Polyphenol supplementation benefits human health via gut microbiota: a systematic review via meta-analysis. J Funct Foods 66:103829. https://doi.org/10.1016/j.jff.2020.103829
Kelainy EG, Ibrahim Laila IM, Ibrahim SR (2019) The effect of ferulic acid against lead-induced oxidative stress and DNA damage in kidney and testes of rats. Environ Sci Pollut Res 26:31675–31684. https://doi.org/10.1007/s11356-019-06099-6
Nash V, Ranadheera CS, Georgousopoulou EN, Mellor DD, Panagiotakos DB, McKune AJ et al (2018) The effects of grape and red wine polyphenols on gut microbiota – A systematic review. Int Food Res J 113:277–287. https://doi.org/10.1016/j.foodres.2018.07.019
Dall’Asta M, Calani L, Tedeschi M, Jechiu L, Brighenti F, Del Rio D, (2012) Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 28:197–203. https://doi.org/10.1016/j.nut.2011.06.005
Grondin JM, Tamura K, Déjean G, Abbott DW, Brumer H (2017) Polysaccharide utilisation loci: fueling microbial communities. J Bacteriol 199:e00860-e916. https://doi.org/10.1128/JB.00860-16
Krizsan SJ, Pang D, Fatehi F, Rinne M, Huhtanen P (2020) Metabolisable energy of grass and red clover silages fed to sheep at maintenance level. Animal 14:753–762. https://doi.org/10.1017/S1751731119002556
Nishizawa C, Ohta T, Egashira Y, Sanada H (1998) Ferulic acid esterase activities of typical intestinal bacteria. Food Sci Technol Int, Tokyo 194:94–97. https://doi.org/10.3136/fsti9596t9798.4.94
Mogodiniyai Kasmaei K, Sundh J (2019) Identification of novel putative bacterial feruloyl esterases from anaerobic ecosystems by use of whole-genome shotgun metagenomics and genome binning. Front Microbiol 10:2673. https://doi.org/10.3389/fmicb.2019.02673
Awika JM, Rose DJ, Simsek S (2018) Complementary effects of cereal and pulse polyphenols and dietary fiber on chronic inflammation and gut health. Food Funct 9:1389–13409. https://doi.org/10.1039/C7FO02011B
Mendez-Encinas MA, Carvajal-Millan E, Rascon-Chu A, Astiazaran-Garcia HF, Valencia-Rivera DE (2018) Ferulated arabinoxylans and their gels: functional properties and potential application as antioxidant and anticancer agent. Oxid Med Cell Longev 2018:e2314759. https://doi.org/10.1155/2018/2314759
Gong L, Wang H, Wang T, Liu Y, Wang J, Sun B (2019) Feruloylated oligosaccharides modulate the gut microbiota in vitro via the combined actions of oligosaccharides and ferulic acid. J Funct Foods 60:103453. https://doi.org/10.1016/j.jff.2019.103453
Al-Khafaji AH, Jepsen SD, Christensen KR, Vigsnæs LK (2020) The potential of human milk oligosaccharides to impact the microbiota-gut-brain axis through modulation of the gut microbiota. J Funct Foods 74:104176. https://doi.org/10.1016/j.jff.2020.104176
Raveendran S, Parameswaran B, Beevi Ummalyma S, Abraham A, Kuruvilla Mathew A, Madhavan A et al (2018) Applications of microbial enzymes in food Industry. Food Technol Biotechnol 56:16–30. https://doi.org/10.17113/ftb.56.01.18.5491
Wong DW, Chan VJ, Liao H (2019) Metagenomic discovery of feruloyl esterases from rumen microflora. Appl Microbiol Biotechnol 103:8449–8457. https://doi.org/10.1007/s00253-019-10102-y
Chen M, Liu S, Imam KM, Uddin S, Sun L, Wang Y et al (2020) The effect of xylooligosaccharide, xylan, and whole wheat bran on the human gut bacteria. Front Microbiol 11:2936. https://doi.org/10.3389/fmicb.2020.568457
Kovatcheva-Datchary P, Shoaie S, Lee S, Wahlström A, Nookaew I, Hallen A et al (2019) Simplified intestinal microbiota to study microbe-diet-host interactions in a mouse model. Cell Rep 26:3772–3783. https://doi.org/10.1016/j.celrep.2019.02.090
Pereira GV, Abdel-Hamid AM, Dutta S, D’Alessandro-Gabazza CN, Wefers D, Farris JA et al (2021) Degradation of complex arabinoxylans by human colonic Bacteroidetes. Nat Commun 12:459. https://doi.org/10.1038/s41467-020-20737-5
Hameleers L, Penttinen L, Ikonen M, Jaillot L, Fauré R, Terrapon N et al (2021) Polysaccharide utilisation loci-driven enzyme discovery reveals BD-FAE: a bifunctional feruloyl and acetyl xylan esterase active on complex natural xylans. Biotechnol Biofuels 14:127. https://doi.org/10.1186/s13068-021-01976-0
Wang K, Pereira GV, Cavalcante JJV, Zhang M, Mackie R, Cann I (2016) Bacteroides intestinalis DSM 17393, a member of the human colonic microbiome, upregulates multiple endoxylanases during growth on xylan. Sci Rep 6:34360. https://doi.org/10.1038/srep34360
Fehlner-Peach H, Magnabosco C, Raghavan V, Scher JU, Tett A, Cox LM et al (2019) Distinct polysaccharide utilisation profiles of human intestinal Prevotella copri isolates. Cell Host Microbe 26:680–690. https://doi.org/10.1016/j.chom.2019.10.013
Dimarogona M, Topakas E, Christakopoulos P, Chrysina ED (2020) The crystal structure of a Fusarium oxysporum feruloyl esterase that belongs to the tannase family. FEBS Lett 594:1738–1749. https://doi.org/10.1002/1873-3468.13776
Wang X, Geng X, Egashira Y, Sanada H (2004) Purification and characterization of a feruloyl esterase from the intestinal bacterium Lactobacillus acidophilus. Appl Environ Microbiol 70:2367–2372. https://doi.org/10.1128/AEM.70.4.2367-2372.2004
Su R, Ni K, Wang T, Yang X, Zhang J, Liu Y et al (2019) Effects of ferulic acid esterase-producing Lactobacillus fermentum and cellulase additives on the fermentation quality and microbial community of alfalfa silage. PeerJ 7:e7712. https://doi.org/10.7717/peerj.7712
Nieter A, Kelle S, Linke D, Berger RG (2017) A p-coumaroyl esterase from Rhizoctonia solani with a pronounced chlorogenic acid esterase activity. New Biotechnol 37:153–161. https://doi.org/10.1016/j.nbt.2017.01.002
Kmezik C, Mazurkewich S, Meents T, McKee LS, Idström A, Armeni M et al (2021) A polysaccharide utilisation locus from the gut bacterium Dysgonomonas mossii encodes functionally distinct carbohydrate esterases. J Biol Chem. https://doi.org/10.1016/j.jbc.2021.100500
Dilokpimol A, Mäkelä MR, Aguilar-Pontes MV, Benoit-Gelber I, Hildén KS, de Vries RP (2016) Diversity of fungal feruloyl esterases: updated phylogenetic classification, properties, and industrial applications. Biotechnol Biofuels 9:231. https://doi.org/10.1186/s13068-016-0651-6
Underlin EN, Frommhagen M, Dilokpimol A, van Erven G, de Vries RP, Kabel MA (2020) Feruloyl esterases for biorefineries: subfamily classified specificity for natural substrates. Front Bioeng Biotechnol 8:332. https://doi.org/10.3389/fbioe.2020.00332
Hunt CJ, Antonopoulou I, Tanksale A, Rova U, Christakopoulos P, Haritos VS (2017) Insights into substrate binding of ferulic acid esterases by arabinose and methyl hydroxycinnamate esters and molecular docking. Sci Rep 7:17315. https://doi.org/10.1038/s41598-017-17260-x
Dilokpimol A, Mäkelä MR, Mansouri S, Belova O, Waterstraat M, Bunzel M et al (2017) Expanding the feruloyl esterase gene family of Aspergillus niger by characterization of a feruloyl esterase, FaeC. New Biotechnol 37:200–209. https://doi.org/10.1016/j.nbt.2017.02.007
Ohlhoff CW, Kirby BM, Van Zyl L, Mutepfa DLR, Casanueva A, Huddy RJ et al (2015) An unusual feruloyl esterase belonging to family VIII esterases and displaying a broad substrate range. J Mol Catal B Enzymatic 118:79–88. https://doi.org/10.1016/j.molcatb.2015.04.010
Gruninger RJ, Cote C, McAllister TA, Abbott DW (2016) Contributions of a unique β-clamp to substrate recognition illuminates the molecular basis of exolysis in ferulic acid esterases. Biochem J 473:839–849. https://doi.org/10.1042/BJ20151153
Uraji M, Tamura H, Mizohata E, Arima J, Wan K, Ogawa K et al (2017) Loop of Streptomyces feruloyl esterase plays an important role in the enzyme’s catalyzing the release of ferulic acid from biomass. Appl Environ Microbiol 84:e02300-e2317. https://doi.org/10.1128/AEM.02300-17
Kaur H, Lekhak MM, Chahal S, Goutam U, Jha P, Naidoo D, Ochatt SJ, Kumar V (2020) Nardostachys jatamansi (D.Don) DC.: an invaluable and constantly dwindling resource of the Himalayas. S Afr J Bot 135:252–267. https://doi.org/10.1016/j.sajb.2020.08.010
Kaur S, Dhiman M, Mantha AK (2018) Ferulic Acid: A natural antioxidant with application towards neuroprotection against Alzheimer’s disease. In: Rani V, Yadav UCS (eds) Functional food and human health. Springer, Singapore, pp 575–586. https://doi.org/10.1007/978-981-13-1123-9_25
Pavelyev RS, Bondar OV, Nguyen TNT, Ziganshina AA, Al Farroukh M, Karwt R et al (2018) Synthesis and in vitro antitumor activity of novel alkenyl derivatives of pyridoxine, bioisosteric analogs of feruloyl methane. Bioorg Med Chem 26:5824–5837. https://doi.org/10.1016/j.bmc.2018.10.031
Andrade S, Ramalho MJ, Loureiro JA, Pereira MC (2021) The biophysical interaction of ferulic acid with liposomes as biological membrane model: The effect of the lipid bilayer composition. J Mol Liq 324:114689. https://doi.org/10.1016/j.molliq.2020.114689
Salau VF, Erukainure OL, Ibeji CU, Olasehinde TA, Koorbanally NA, Islam MdS (2020) Ferulic acid modulates dysfunctional metabolic pathways and purinergic activities, while stalling redox imbalance and cholinergic activities in oxidative brain injury. Neurotox Res 37:944–955. https://doi.org/10.1007/s12640-019-00099-7
Zduńska K, Dana A, Kolodziejczak A, Rotsztejn H (2018) Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol Physiol 31:332–336. https://doi.org/10.1159/000491755
Mohamed MK, Ramamurthy V (2021) The modulating effect of ferulic acid on high fat diet induced hyperlipidemia and obesity: a dose response study in male Sprague Dawley rats. Biomedicine 41:413–420. https://doi.org/10.51248/.v41i2.1049
Di Giacomo S, Percaccio E, Gullì M, Romano A, Vitalone A, Mazzanti G, Gaetani S, Di Sotto A (2022) Recent advances in the neuroprotective properties of ferulic acid in Alzheimer’s disease: a narrative review. Nutrients 14:3709. https://doi.org/10.3390/nu14183709
Cheng C-Y, Tang N-Y, Kao S-T, Hsieh C-L (2016) Ferulic acid administered at various time points protects against cerebral infarction by activating p38 MAPK/p90RSK/CREB/Bcl-2 anti-apoptotic signaling in the subacute phase of cerebral ischemia-reperfusion injury in rats. PLoS ONE 11:e0155748. https://doi.org/10.1371/journal.pone.0155748
Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S (2017) Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 74:3769–3787. https://doi.org/10.1007/s00018-017-2550-9
Tan LY, Yeo XY, Bae H-G, Lee DPS, Ho RC, Kim JE, Jo D-G, Jung S (2021) Association of gut microbiome dysbiosis with neurodegeneration: can gut microbe-modifying diet prevent or alleviate the symptoms of neurodegenerative diseases? Life 11:698. https://doi.org/10.3390/life11070698
Singh N, Singh V, Rai SN, Mishra V, Vamanu E, Singh MP (2022) Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes. Biomed Pharmacother 156:113958. https://doi.org/10.1016/j.biopha.2022.113958
Denver P, McClean PL (2018) Distinguishing normal brain aging from the development of Alzheimer’s disease: inflammation, insulin signaling and cognition. Neural Regen Res 13:1719–1730. https://doi.org/10.4103/1673-5374.238608
Repsold BP, Malan SF, Joubert J, Oliver DW (2018) Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates. SAR QSAR Environ Res 29:231–255. https://doi.org/10.1080/1062936X.2018.1423641
Mishra P, Kumar A, Panda G (2019) Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018). Bioorg Med Chem 27:895–930. https://doi.org/10.1016/j.bmc.2019.01.025
He F, Chou CJ, Scheiner M, Poeta E, Yuan Chen N, Gunesch S et al (2021) Melatonin-and ferulic acid-based HDAC6 selective inhibitors exhibit pronounced immunomodulatory effects in vitro and neuroprotective effects in a pharmacological Alzheimer’s disease mouse model. J Med Chem 64:3794–3812. https://doi.org/10.1021/acs.jmedchem.0c01940
Sang Z, Wang K, Han X, Cao M, Tan Z, Liu W (2018) Design, synthesis, and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease. ACS Chem Neurosci 10:1008–1024. https://doi.org/10.1021/acschemneuro.8b00530
Xu W, Wang X-B, Wang Z-M, Wu J-J, Li F, Wang J et al (2016) Synthesis and evaluation of donepezil–ferulic acid hybrids as multi-target-directed ligands against Alzheimer’s disease. Med Chem Commun 7:990–998. https://doi.org/10.1039/C6MD00053C
Zhang X, He X, Chen Q, Lu J, Rapposelli S, Pi R (2018) A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer’s disease. Bioorg Med Chem 26:543–550. https://doi.org/10.1016/j.bmc.2017.12.042
Dohrmann DD, Putnik P, Bursać Kovačević D, Simal-Gandara J, Lorenzo JM, Barba FJ (2019) Japanese, Mediterranean and Argentinean diets and their potential roles in neurodegenerative diseases. Int Food Res J 120:464–477. https://doi.org/10.1016/j.foodres.2018.10.090
Hornedo-Ortega R, Cerezo AB, de Pablos RM, Krisa S, Richard T, García-Parrilla MC et al (2018) Phenolic compounds characteristic of the Mediterranean diet in mitigating microglia-mediated neuroinflammation. Front Cell Neurosci 12:373. https://doi.org/10.1007/978-981-13-1123-9_25
Weng M, Xie X, Liu C, Lim K-L, Zhang C-W, Li L (2018) The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson’s disease. Parkinsons Dis 2018:9163040. https://doi.org/10.1155/2018/9163040
Anis E, Zafeer MF, Firdaus F, Islam SN, Anees Khan A, Ali A et al (2020) Ferulic acid reinstates mitochondrial dynamics through PGC1α expression modulation in 6-hydroxydopamine lesioned rats. Phytother Res 34:214–226. https://doi.org/10.1002/ptr.6523
Ojha S, Javed H, Azimullah S, Khair SBA, Haque ME (2015) Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease. Drug Des Devel Ther 9:5499. https://doi.org/10.2147/DDDT.S90616
Cui L, Zhang Y, Cao H, Wang Y, Teng T, Ma G, Li Y, Li K, Zhang Y (2013) Ferulic acid inhibits the transition of amyloid-β 42 monomers to oligomers but accelerates the transition from oligomers to fibrils. J Alzheimers Dis 37:19–28. https://doi.org/10.3233/JAD-130164
Dong Q, Yang S, Liao H, He Q, Xiao J (2023) Bioinformatics findings reveal the pharmacological properties of ferulic acid treating traumatic brain injury via targeting of ferroptosis. Int J Food Prop 26:778–786. https://doi.org/10.1080/10942912.2023.2185178
Ono K, Hirohata M, Yamada M (2005) Ferulic acid destabilizes preformed β-amyloid fibrils in vitro. BBRC 336:444–449. https://doi.org/10.1016/j.bbrc.2005.08.148
Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA (2005) Ferulic acid ethyl ester protects neurons against amyloid β- peptide(1–42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 92:749–758. https://doi.org/10.1111/j.1471-4159.2004.02899.x
Takahashi R, Ono K, Takamura Y, Mizuguchi M, Ikeda T, Nishijo H, Yamada M (2015) Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity. J Neurochem 134:943–955. https://doi.org/10.1111/jnc.13180
Li X, Zhang J, Rong H, Zhang X, Dong M (2020) Ferulic acid ameliorates MPP+/MPTP-induced oxidative stress via ERK1/2-dependent Nrf2 activation: translational implications for Parkinson disease treatment. Mol Neurobiol 57:2981–2995. https://doi.org/10.1007/s12035-020-01934-1
Kim H-S, Cho J, Kim D-H, Yan J-J, Lee H-K, Suh H-W, Song D-K (2004) Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of β-amyloid peptide (1–42) in mice. Biol Pharm Bull 27:120–121. https://doi.org/10.1248/bpb.27.120
Yan J-J, Cho J-Y, Kim H-S, Kim K-L, Jung J-S, Huh S-O, Suh H-W, Kim Y-H, Song D-K (2001) Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133:89–96. https://doi.org/10.1038/sj.bjp.0704047
Jin Y, Yan E, Fan Y, Zong Z, Qi Z, Li Z (2005) Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol Sin 26:943–951. https://doi.org/10.1111/j.1745-7254.2005.00158.x
Hussein AM, Abbas KM, Abulseoud OA, El-Hussainy E-HMA (2017) Effects of ferulic acid on oxidative stress, heat shock protein 70, connexin 43, and monoamines in the hippocampus of pentylenetetrazole-kindled rats. Can J Physiol Pharmacol 95:732–742. https://doi.org/10.1139/cjpp-2016-0219
Mori T, Koyama N, Tan J, Segawa T, Maeda M, Town T (2019) Combined treatment with the phenolics (−)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice. J Biol Chem 294:2714–5444. https://doi.org/10.1074/jbc.RA118.004280
Nagarajan S, Chellappan DR, Chinnaswamy P, Thulasingam S (2015) Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL/6 mice. Pharm Biol 53:1591–1601. https://doi.org/10.3109/13880209.2014.993041
Askar MH, Hussein AM, Al-Basiony SF, Meseha RK, Metias EF, Salama MM et al (2019) Effects of exercise and ferulic acid on alpha synuclein and neuroprotective heat shock protein 70 in an experimental model of Parkinsonism disease. CNS Neurol Disord Drug Targets 18:156–169. https://doi.org/10.2174/1871527317666180816095707
Zeni ALB, Camargo A, Dalmagro AP (2017) Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice. Steroids 125:131–136. https://doi.org/10.1016/j.steroids.2017.07.006
Yao K, Yang Q, Li Y, Lan T, Yu H, Yu Y (2020) MicroRNA-9 mediated the protective effect of ferulic acid on hypoxic-ischemic brain damage in neonatal rats. PLoS ONE 15:e0228825. https://doi.org/10.1371/journal.pone.0228825
Long T, Wu Q, Wei J, Tang Y, He Y-N, He C-L, Chen X, Yu L, Yu C-L, Law BY-K, Wu J-M, Qin D-L, Wu A-G, Zhou X-G (2022) Ferulic acid exerts neuroprotective effects via autophagy induction in C. elegans and cellular models of Parkinson’s disease. Oxid Med Cell Longev 2022:e3723567. https://doi.org/10.1155/2022/3723567
Ordovas JM, Ferguson LR, Tai ES, Mathers JC (2018) Personalised nutrition and health. BMJ. https://doi.org/10.1136/bmj.k2173
Berry SE, Valdes AM, Drew DA, Asnicar F, Mazidi M, Wolf J et al (2020) Human postprandial responses to food and potential for precision nutrition. Nat Med 26:964–973. https://doi.org/10.1038/s41591-020-0934-0
Sheridan OP, Martin JC, Lawley TD, Browne HP, Harris HMB, Bernalier-Donadille A et al (2016) Polysaccharide utilisation loci and nutritional specialization in a dominant group of butyrate-producing human colonic Firmicutes. Microb Genom 2:e000043. https://doi.org/10.1099/mgen.0.000043
Kohno M, Musashi K, Ikeda HO, Horibe T, Matsumoto A, Kawakami K (2020) Oral administration of ferulic acid or ethyl ferulate attenuates retinal damage in sodium iodate-induced retinal degeneration mice. Sci Rep 10:8688. https://doi.org/10.1038/s41598-020-65673-y
Acknowledgements
The authors thank CSIR-Central Food Technological Research Institute (CFTRI) for providing research facilities. Saarika Pothuvan Kunnummal acknowledges CSIR-Senior Research Fellowship and Mahejibin Khan acknowledges the Indian Council of Medical Research (ICMR) for providing a research grant.
Funding
Funding was received from the Indian Council of Medical Research (ICMR) as a research grant (ICMR Grant no. 5/7/1741/CH/Adhoc/2021-RMBCH).
Author information
Authors and Affiliations
Contributions
MK conceptualised the review, SPK performed the literature search and data analysis, wrote the first draft and all the authors drafted and/or critically revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Human and animal rights and informed consent
This article contains no studies with human or animal subjects performed by the authors.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kunnummal, S.P., Khan, M. Diet–gut microbiome interaction and ferulic acid bioavailability: implications on neurodegenerative disorders. Eur J Nutr 63, 51–66 (2024). https://doi.org/10.1007/s00394-023-03247-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-023-03247-0